Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

37,689 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
S100A9+CD14+ monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function.
Tu X, Chen L, Zheng Y, Mu C, Zhang Z, Wang F, Ren Y, Duan Y, Zhang H, Tong Z, Liu L, Sun X, Zhao P, Wang L, Feng X, Fang W, Liu X. Tu X, et al. Among authors: zheng y. J Exp Clin Cancer Res. 2024 Mar 8;43(1):72. doi: 10.1186/s13046-024-02985-1. J Exp Clin Cancer Res. 2024. PMID: 38454445 Free PMC article.
Carcinoma of Unknown Primary with EML4-ALK Fusion Response to ALK Inhibitors.
Zhao P, Peng L, Wu W, Zheng Y, Jiang W, Zhang H, Tong Z, Liu L, Ma R, Wang L, Yao M, Wang K, Fang W, Wu L. Zhao P, et al. Among authors: zheng y. Oncologist. 2019 Apr;24(4):449-454. doi: 10.1634/theoncologist.2018-0439. Epub 2019 Jan 24. Oncologist. 2019. PMID: 30679319 Free PMC article.
37,689 results
You have reached the last available page of results. Please see the User Guide for more information.